JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PLYM
3926
DELISTED
Plymouth Industrial REIT
PLYM
| $291K | ﹤0.01% |
22,758
-63,296
| -74% | -$840K |
2018 Q3
7 quarters
|
|
3927
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.3B
| $291K | ﹤0.01% |
10,527
-470
| -4% | -$12.3K |
2015 Q4
18 quarters
|
|
|
KA
3928
DELISTED
Kineta, Inc. Common Stock
KA
| $291K | ﹤0.01% |
1,518
| – | – |
2016 Q1
17 quarters
|
|
3929
Primis Financial Corp
FRST
$385M
| $290K | ﹤0.01% |
29,902
-20,047
| -40% | -$193K |
2016 Q1
17 quarters
|
|
3930
Petrobras
PBR
$156B
| $288K | ﹤0.01% |
34,803
-65,709
| -65% | -$476K |
2013 Q2
28 quarters
|
|
3931
Philips
PHG
$23.4B
| $287K | ﹤0.01% |
7,570
-135,494
| -95% | -$4.72M |
2013 Q2
28 quarters
|
|
|
TGH
3932
DELISTED
Textainer Group Holdings limited
TGH
| $285K | ﹤0.01% |
34,932
+17,636
| +102% | +$144K |
2016 Q4
14 quarters
|
|
3933
Vanguard Materials ETF
VAW
$2.87B
| $283K | ﹤0.01% |
2,352
-183
| -7% | -$20.6K |
2015 Q4
18 quarters
|
|
|
EVFM
3934
CALL
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $283K | ﹤0.01% |
+6,667
| New | +$449K |
2020 Q2
0 quarters
|
|
3935
Teekay Tankers
TNK
$3.59B
| $282K | ﹤0.01% |
22,002
-222,292
| -91% | -$3.93M |
2016 Q4
14 quarters
|
|
|
EBIX
3936
DELISTED
Ebix Inc
EBIX
| $282K | ﹤0.01% |
12,620
-32,809
| -72% | -$676K |
2016 Q4
14 quarters
|
|
3937
Accel Entertainment
ACEL
$883M
| $280K | ﹤0.01% |
+29,017
| New | +$265K |
2020 Q2
0 quarters
|
|
3938
CALL
Innoviva
INVA
$1.49B
| $280K | ﹤0.01% |
20,000
-300,000
| -94% | -$4.08M |
2020 Q1
1 quarter
|
|
|
IMGN
3939
DELISTED
Immunogen Inc
IMGN
| $280K | ﹤0.01% |
61,049
+3,214
| +6% | +$13.7K |
2016 Q4
14 quarters
|
|
|
KDMN
3940
DELISTED
Kadmon Holdings, Inc.
KDMN
| $279K | ﹤0.01% |
54,508
-388,127
| -88% | -$1.74M |
2018 Q2
8 quarters
|
|
3941
American Superconductor
AMSC
$1.45B
| $278K | ﹤0.01% |
34,300
-314,695
| -90% | -$2.06M |
2015 Q4
18 quarters
|
|
3942
Global X SuperDividend US ETF
DIV
$762M
| $278K | ﹤0.01% |
+18,559
| New | +$272K |
2020 Q2
0 quarters
|
|
3943
Anika Therapeutics
ANIK
$264M
| $277K | ﹤0.01% |
7,347
+153
| +2% | +$5.04K |
2015 Q4
18 quarters
|
|
3944
Relmada Therapeutics
RLMD
$371M
| $277K | ﹤0.01% |
+6,186
| New | +$262K |
2020 Q2
0 quarters
|
|
3945
Lindblad Expeditions
LIND
$2.33B
| $276K | ﹤0.01% |
35,699
-8,575
| -19% | -$59.2K |
2017 Q4
10 quarters
|
|
|
VWTR
3946
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $276K | ﹤0.01% |
32,794
-12,730
| -28% | -$102K |
2016 Q4
14 quarters
|
|
|
GOEVW
3947
DELISTED
Canoo Inc. Warrant
GOEVW
| – | – |
0
| – | – |
2020 Q2
0 quarters
|
|
|
STFC
3948
DELISTED
State Auto Financial Corp
STFC
| $275K | ﹤0.01% |
15,421
-11,316
| -42% | -$243K |
2016 Q4
14 quarters
|
|
|
CNST
3949
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $274K | ﹤0.01% |
9,140
+3,011
| +49% | +$108K |
2018 Q3
7 quarters
|
|
3950
Amphastar Pharmaceuticals
AMPH
$1.08B
| $273K | ﹤0.01% |
12,175
-16,204
| -57% | -$297K |
2014 Q3
23 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.